AstraZeneca says on track to deliver on Covid shots as sales hit $275 mln

AstraZeneca said its Covid-19 vaccine sales were $275 million in the first-quarter and it is on track to deliver 200 million doses a month from April, as better-than-expected results and a second half growth forecastboosted its shares.